BR9808251B1 - vacina, e, uso de uma proteìna isolada ou recombinante ou fragmento antigênico da mesma. - Google Patents

vacina, e, uso de uma proteìna isolada ou recombinante ou fragmento antigênico da mesma.

Info

Publication number
BR9808251B1
BR9808251B1 BRPI9808251-5A BR9808251A BR9808251B1 BR 9808251 B1 BR9808251 B1 BR 9808251B1 BR 9808251 A BR9808251 A BR 9808251A BR 9808251 B1 BR9808251 B1 BR 9808251B1
Authority
BR
Brazil
Prior art keywords
vaccine
isolated
recombinant protein
antigenic fragment
antibodies
Prior art date
Application number
BRPI9808251-5A
Other languages
English (en)
Other versions
BR9808251A (pt
Inventor
Milligen Florine Johanna Van
Johannes Bernardus Wilhelmus Joseph Cornelissen
Bernard Adri Bokhout
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR9808251A publication Critical patent/BR9808251A/pt
Publication of BR9808251B1 publication Critical patent/BR9808251B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/641—Cysteine endopeptidases (3.4.22)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
    • G01N2333/43526—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms
    • G01N2333/43547—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms from trematodes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Environmental Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
BRPI9808251-5A 1997-03-11 1998-03-11 vacina, e, uso de uma proteìna isolada ou recombinante ou fragmento antigênico da mesma. BR9808251B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97200730 1997-03-11
PCT/NL1998/000146 WO1998040497A2 (en) 1997-03-11 1998-03-11 An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method

Publications (2)

Publication Number Publication Date
BR9808251A BR9808251A (pt) 2000-05-16
BR9808251B1 true BR9808251B1 (pt) 2012-09-04

Family

ID=8228093

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9808251-5A BR9808251B1 (pt) 1997-03-11 1998-03-11 vacina, e, uso de uma proteìna isolada ou recombinante ou fragmento antigênico da mesma.

Country Status (11)

Country Link
US (5) US6551594B1 (pt)
EP (1) EP0966537B1 (pt)
JP (1) JP4321881B2 (pt)
AT (1) ATE420184T1 (pt)
AU (1) AU6424298A (pt)
BR (1) BR9808251B1 (pt)
CA (1) CA2284110C (pt)
DE (1) DE69840433D1 (pt)
NZ (1) NZ337697A (pt)
TR (1) TR199902609T2 (pt)
WO (1) WO1998040497A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69840433D1 (de) 1997-03-11 2009-02-26 Stichting Dienst Landbouwkundi Fasciola hepatica impfstoffe
ES2184569B1 (es) * 2000-08-07 2004-02-01 Inst Nac Investigacion Inia Empleo de los productos de excrecion secrecion de fasciola hepatica en la elaboracion de un medicamento para el tratamiento de enfermedades hepaticas y/o para evitar o reducir el rechazo al transplante hepatico.
US20040091914A1 (en) * 2002-08-02 2004-05-13 Sysmex Corporation Gene assay method for predicting glaucoma onset risk
AU2006322887A1 (en) * 2005-12-05 2007-06-14 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin Compositions and methods for modulating an immune response
AU2016233223A1 (en) 2015-03-18 2017-09-14 The United States Government, As Represented By The Secretary Of The Department Of Health And Human Services Immunogenic compositions and vaccines for preventing or treating filarial disease
GB201714057D0 (en) * 2017-09-01 2017-10-18 Univ College Dublin Nat Univ Of Ireland Dublin A fasciola hepatica antigen and vaccine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8432401D0 (en) * 1984-12-21 1985-02-06 Bennett C E Liver fluke antigens
PT666919E (pt) * 1992-10-21 2003-09-30 John Pius Dalton Vacina contendo uma protease de tiol
JPH07505787A (ja) * 1993-02-05 1995-06-29 ダラテク・プロプライエタリー・リミテッド ファスキオラ種から取得可能なポリペプチド類，およびワクチン，処置法およびそのｄｎａ配列
US5756662A (en) 1995-03-14 1998-05-26 Corixa Corporation Compounds and methods for the detection of T. cruzi infection
DE69840433D1 (de) 1997-03-11 2009-02-26 Stichting Dienst Landbouwkundi Fasciola hepatica impfstoffe

Also Published As

Publication number Publication date
TR199902609T2 (xx) 2000-06-21
US20100285049A1 (en) 2010-11-11
CA2284110C (en) 2012-08-28
US6551594B1 (en) 2003-04-22
WO1998040497A3 (en) 1998-12-10
ATE420184T1 (de) 2009-01-15
US7744907B2 (en) 2010-06-29
WO1998040497A2 (en) 1998-09-17
US20030224007A1 (en) 2003-12-04
US20080138358A1 (en) 2008-06-12
NZ337697A (en) 2001-06-29
US20120107342A1 (en) 2012-05-03
BR9808251A (pt) 2000-05-16
EP0966537B1 (en) 2009-01-07
CA2284110A1 (en) 1998-09-17
US8088909B2 (en) 2012-01-03
EP0966537A2 (en) 1999-12-29
DE69840433D1 (de) 2009-02-26
AU6424298A (en) 1998-09-29
US8507658B2 (en) 2013-08-13
JP2001527391A (ja) 2001-12-25
JP4321881B2 (ja) 2009-08-26

Similar Documents

Publication Publication Date Title
CY1114164T1 (el) Μεθοδος ελεγχου της δραστικοτητας ανοσολογικα λειτουργικου μοριου
TR200102497T2 (tr) Yeni streptococcus antijenleri
FI870447A0 (fi) Htlv-iii-hoeljepeptider.
DK0616613T3 (da) Fragmenter af prionprotein
ES2058049T1 (es) Composicion peptidica.
NO2013009I1 (no) Alipogen tiparvovec
DK0914331T3 (da) Neuroaktive peptider
DE68924928D1 (de) Antikörper gegen latente Proteine von menschlichen Papillomavirus, diagnostische Systeme und Methoden.
DK152082A (da) Anvendelse af radiomaerket peptid afledt af tvaerbundet fibrin til at lokalisere blodpropper in vivo
EE03693B1 (et) Isoleeritud dimeerne fibroblastide aktivatsioonivalk alfa ja selle kasutusalad
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
CO5231139A1 (es) Vacuna alergicas
ATE160575T1 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
BR9808251B1 (pt) vacina, e, uso de uma proteìna isolada ou recombinante ou fragmento antigênico da mesma.
DK0470980T3 (da) Syntetiske peptider til en HIV-1-vaccine
DK0538341T3 (da) EHV-4-gycoproteinvaccine.
SE9604581D0 (sv) An agent against cancer and virus infections
CY1106349T1 (el) Συστηματα ανιχνευσης ανοσοπροσδιορισμου ιικου αντιγονου ηπατιτιδας c
DK0826006T3 (da) Transepitel transport af molekylearter
ATE435034T1 (de) Expression und charakterisierung eines hiv-1 hüllproteins, das mit einer breitreaktiven neutralisierenden antikörperantwort assoziiert ist.
ATE109158T1 (de) Rubella-e1 und c peptide.
DE69028561D1 (de) Immunoassay zum Nachweis von Antikörpern gegen HIV
ES2308850T3 (es) Anticuerpos para antigenos de celulas de langerhans de mamiferos y sus usos.
DK1077999T3 (da) Moraxella catarrhalis-proteiner
DK0792291T3 (da) Protein, der påvirker KATP-kanaler

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK (NL)

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020070000611/RJ DE 02/01/2007.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 04/09/2012, OBSERVADAS AS CONDICOES LEGAIS.

B25D Requested change of name of applicant approved
B25G Requested change of headquarter approved
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 21A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2505 DE 08-01-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.